about
MicroRNA-513 regulates B7-H1 translation and is involved in IFN-gamma-induced B7-H1 expression in cholangiocytesBiology of Cholangiocytes: From Bench to BedsideRevisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial PhenotypeUpdate on Sclerosing Cholangitis in Critically Ill PatientsDifferentially expressed adenylyl cyclase isoforms mediate secretory functions in cholangiocyte subpopulation.A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosisThe role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in miceHeterogeneity of the intrahepatic biliary epitheliumMammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts.ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.Foxa1 and Foxa2 regulate bile duct development in mice.Involvement of cholangiocyte proliferation in biliary fibrosis.Role of lipid rafts in liver health and diseaseYin-Chen-Hao-Tang alleviates biliary obstructive cirrhosis in rats by inhibiting biliary epithelial cell proliferation and activation.Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in miceActivation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation.Ezrin finds its groove in cholangiocytesCharacterization of animal models for primary sclerosing cholangitis (PSC).Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling.The crucial role of cholangiocytes in cholangiopathiesCholangiocytes and blood supply.Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis.Mutation of zebrafish Snapc4 is associated with loss of the intrahepatic biliary networkInflammation and liver.Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by down-regulating microRNA-513.Diffuse Caroli's disease with atypical presentation: a case report.Recent advances in the morphological and functional heterogeneity of the biliary epitheliumFXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway.Vascular factors, angiogenesis and biliary tract diseaseEpithelial-mesenchymal interactions in biliary diseasesPolycystic liver diseases: congenital disorders of cholangiocyte signalingDevelopment of the bile ducts: essentials for the clinical hepatologist.Vascular biology of the biliary epitheliumAdenylyl cyclases in the digestive system.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells.Expression of mediators of purinergic signaling in human liver cell lines.Liver - guardian, modifier and target of sepsis.Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
P2860
Q24644382-6B63D886-BC74-4AD5-A7E7-0036654298FBQ26738866-F92E3DF8-C87B-42ED-857F-C09D352D783BQ26765903-B46B2784-4159-415E-9E95-2136A39037E8Q26782875-ED755460-9AE1-4FDE-807E-4F5A81430734Q28566509-8F9C0183-D15F-4A5C-B2B2-F2F3BA42C4A6Q30479829-773A53A0-4CED-4878-B1BC-6C9F7C86D3B9Q30613139-010D3E5E-F5F4-4CF5-BBAE-A817674ADEB6Q33866793-BE9B4B98-D7C6-4318-AAF1-8C8518E978BEQ34091331-36F6374C-7E5F-4C2B-A5CB-3752E1BCBD0CQ34178858-87BCEF3D-6AAE-4746-B11B-6991267F38F8Q34399971-D31CB817-FD39-48F8-9361-DB557C91E40AQ34658511-6DD30946-5E8C-4528-95AD-A0B4F2BBB9EFQ34992326-DBD9EA07-7659-4A5C-A69D-686E201D3174Q35012726-3C844D1D-D372-436F-A63A-9413E7C19E15Q35228653-0B6E3D38-A836-4366-A683-E1980791F531Q35269164-F2E8B733-A5A8-40B1-A213-590ECE52DA6EQ35437089-1EB5A0DD-D611-4F48-8703-411C26C36226Q35528054-8F9B8833-4FA8-48B0-ACE6-B3F1A5902A76Q35896870-DB6D323E-FAC8-4946-ACCC-24DA10ED5B24Q35915987-90EE5EBA-4643-4E50-8DF0-E419662FEEB1Q36113261-1DA442C3-DFAA-4351-B70E-ABDC9F3B0482Q36506488-5F6C6575-6BE7-4293-AD65-1CCFCDB333E2Q36606886-13F7B396-8FD1-4FB2-857C-10CFD3B0BE95Q37014441-2F6DFD3A-7DD5-4E8B-A53B-157F52A82F7DQ37313768-64F7548B-3AFC-440F-A927-5386C87EC4C9Q37468151-52BFD6B4-5D3D-4899-9919-BCD5ABC06C86Q37647710-58E8E490-15F8-4D76-95FE-A247F43AA8A8Q37662251-DCB46297-ED39-4712-B04D-3F6205D22647Q37666302-181FBC14-E9D3-44FD-BF88-3F49916D43B8Q37671557-2A0CC925-71B3-4EA2-98D5-95A2C2CFFFE6Q37846143-259FD959-6E61-42CD-9FE9-A6FC21F477E7Q37868328-6F0F4C49-3F0A-4299-8023-AF8E7E704F14Q37975904-B00A65EC-65A5-4A68-8622-5B022B5940A6Q38121567-D75ED758-DA7C-4778-A0E7-914E17BEB154Q38187513-7ECE6B6F-2221-4BC6-8664-34E54397EE20Q38720813-A1ED5962-96D0-4F5C-A98A-02CCECDF4E7EQ38819131-B2B4C790-8582-490B-832A-496637736102Q38959199-5B0232A0-DD66-48AF-B359-968F6125C3C4Q39031051-8F75772D-794C-4E94-BBC1-147B9F4D04E9Q39105803-E845A7A6-7E1F-4D78-9932-424D3D5CDA3F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Pathophysiology of cholangiopathies.
@ast
Pathophysiology of cholangiopathies.
@en
type
label
Pathophysiology of cholangiopathies.
@ast
Pathophysiology of cholangiopathies.
@en
prefLabel
Pathophysiology of cholangiopathies.
@ast
Pathophysiology of cholangiopathies.
@en
P2093
P1476
Pathophysiology of cholangiopathies.
@en
P2093
Carlo Spirli
Luca Fabris
Mario Strazzabosco
P304
P356
10.1097/01.MCG.0000155549.29643.AD
P433
P577
2005-04-01T00:00:00Z